| Drug Name: | Mirabegron (223673-61-8) |
|---|---|
| PubChem ID: | 9865528 |
| SMILES: | C1=CC=C(C=C1)[C@H](CNCCC2=CC=C(C=C2)NC(=O)CC3=CSC(=N3)N)O |
| InchiKey: | PBAPPPCECJKMCM-IBGZPJMESA-N |
| Therapeutic Category: | Adrenergic Agents, Adrenergic Agonists, Adrenergic beta-3 Receptor Agonists, Adrenergic beta-Agonists, Neurotransmitter Agents, Urological Agents |
| Molecular Weight (dalton) | : | 396.516 |
| LogP | : | 2.7722 |
| Ring Count | : | 3 |
| Hydrogen Bond Acceptor Count | : | 6 |
| Hydrogen Bond Donor Count | : | 4 |
| Total Polar Surface Area | : | 100.27 |
This panel provides information on interacting drugs and their ADRs along with references
| Interacting drug | Toxicity | Interaction Type | Mechanism | Reference |
|---|
This panel provides drug-protein interaction and their ADRs along with references
| Toxicity | Interacting Protein | Mechanism | Reference |
|---|
This panel provides drug-food interactions and their ADRs along with references
| Food | Toxicity | Reference |
|---|
This panel provides information on metabolites and their ADRs along with references
| Metabolite | Toxicity | Place of Metabolism | Mechanism | Reference |
|---|
This panel provides information on drug category